Celerion and Ricerca Biosciences have formed a biosimilars alliance focused on preclinical and early clinical assessment of biologics manufactured by a new supplier. The Biosimilars Alliance will offer access to all of the services required to perform early assessment of the viability of a potential biosimilar product before initiating multi-center comparator studies in the target patient populations.   Services include in vitro and in vivo pharmacological assessments of activity and toxicologic...